Cita APA

Taylor, P., Keystone, E., Van der Heijde, D., Weinblatt, M., del Carmen Morales, L., Reyes Gonzaga, J., . . . Tanaka, Y. (2017). Baricitinib versus placebo or adalimumab in rheumatoid arthritis. Massachusetts Medical Society.

Citación estilo Chicago

Taylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.

Cita MLA

Taylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.

Warning: These citations may not always be 100% accurate.